{"id":17197,"date":"2023-07-25T09:44:36","date_gmt":"2023-07-25T13:44:36","guid":{"rendered":"https:\/\/www.progeriaresearch.org\/?p=17197"},"modified":"2025-02-15T17:45:18","modified_gmt":"2025-02-15T22:45:18","slug":"nord","status":"publish","type":"post","link":"https:\/\/www.progeriaresearch.org\/ar\/2023\/07\/25\/nord\/","title":{"rendered":"\u064a\u0639\u0645\u0644 \u0627\u0644\u0645\u0624\u0633\u0633 \u0627\u0644\u0645\u0634\u0627\u0631\u0643 \u0644\u0640 PRF \u0643\u0642\u0627\u0626\u062f \u0641\u0643\u0631\u064a \u0641\u064a \u062a\u0637\u0648\u064a\u0631 \u0623\u062f\u0648\u064a\u0629 \u0627\u0644\u0623\u0645\u0631\u0627\u0636 \u0627\u0644\u0646\u0627\u062f\u0631\u0629"},"content":{"rendered":"<p>[et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;0px||0px|||&#8221; locked=&#8221;off&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.16&#8243; background_size=&#8221;initial&#8221; background_position=&#8221;top_left&#8221; background_repeat=&#8221;repeat&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.16&#8243; custom_padding=&#8221;|||&#8221; global_colors_info=&#8221;{}&#8221; custom_padding__hover=&#8221;|||&#8221;][et_pb_image src=&#8221;https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2023\/07\/Lesliewcomputer.png&#8221; title_text=&#8221;Lesliewcomputer&#8221; _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_image][\/et_pb_column][\/et_pb_row][\/et_pb_section][et_pb_section fb_built=&#8221;1&#8243; _builder_version=&#8221;4.17.4&#8243; _module_preset=&#8221;default&#8221; custom_margin=&#8221;||-77px|||&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_row _builder_version=&#8221;4.17.4&#8243; _module_preset=&#8221;default&#8221; min_height=&#8221;414.9px&#8221; custom_margin=&#8221;-88px|auto|-173px|auto||&#8221; custom_padding=&#8221;||45px|||&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_column type=&#8221;4_4&#8243; _builder_version=&#8221;4.17.4&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;][et_pb_text _builder_version=&#8221;4.21.0&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p>PRF\u2019s co-founder and Medical Director, Dr. Leslie Gordon, was recently invited to contribute to an educational video series produced by the National Organization for Rare Disorders (NORD), along with her colleague Dr. Francis Collins, Science Advisor to the President of the U.S. and former Director of the National Institutes of Health (NIH).<\/p>\n<p>The two were asked to share learnings from their experiences in Progeria research, starting as far back as the development of PRF\u2019s International Registry in 1999. In the two videos below, they share takeaways on the Progeria gene finding in 2003, through the development of PRF\u2019s medical &amp; research database, PRF\u2019s natural history study, and finally through the Food and Drug Administration (FDA) approval of lonafarnib, the first-ever treatment for Progeria, to demonstrate possible pathways to advancing research on rare diseases for those involved in rare disease research and advocacy.<\/p>\n<p>[\/et_pb_text][et_pb_button button_url=&#8221;https:\/\/learn.rarediseases.org\/courses\/rare-disease-drug-development-series\/&#8221; url_new_window=&#8221;on&#8221; button_text=&#8221;These videos can be accessed HERE for free in NORD\u2019s Rare Disease Drug Development Series.&#8221; admin_label=&#8221;NORD Dr. Leslie Gordon &#038; Dr. Francis Collins&#8221; _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; button_text_color=&#8221;#FFFFFF&#8221; button_bg_color=&#8221;#29327A&#8221; button_border_color=&#8221;#8FD2ED&#8221; background_layout=&#8221;dark&#8221; global_colors_info=&#8221;{}&#8221;][\/et_pb_button][et_pb_text _builder_version=&#8221;4.22.1&#8243; _module_preset=&#8221;default&#8221; global_colors_info=&#8221;{}&#8221;]<\/p>\n<p><span>This full series is deeply informative for anyone interested in drug development in rare disease, and the interviews with Dr. Gordon and Dr. Collins are located within the module on Natural History Studies within this series.<\/span><\/p>\n<p>[\/et_pb_text][\/et_pb_column][\/et_pb_row][\/et_pb_section]<\/p>\n","protected":false},"excerpt":{"rendered":"<p>\u0627\u0633\u062a\u0645\u0639 \u0625\u0644\u0649 \u0627\u0644\u0645\u0624\u0633\u0633 \u0627\u0644\u0645\u0634\u0627\u0631\u0643 \u0648\u0627\u0644\u0645\u062f\u064a\u0631 \u0627\u0644\u0637\u0628\u064a \u0644\u0640 PRF\u060c \u0627\u0644\u062f\u0643\u062a\u0648\u0631 \u0644\u064a\u0632\u0644\u064a \u062c\u0648\u0631\u062f\u0648\u0646\u060c \u0625\u0644\u0649 \u062c\u0627\u0646\u0628 \u0632\u0645\u064a\u0644\u0647 \u0627\u0644\u0642\u062f\u064a\u0645 \u0627\u0644\u062f\u0643\u062a\u0648\u0631 \u0641\u0631\u0627\u0646\u0633\u064a\u0633 \u0643\u0648\u0644\u064a\u0646\u0632\u060c \u064a\u0634\u0627\u0631\u0643\u0627\u0646 \u0631\u062d\u0644\u062a\u0647\u0645\u0627 \u0641\u064a \u062a\u0637\u0648\u064a\u0631 \u0623\u062f\u0648\u064a\u0629 \u0627\u0644\u0623\u0645\u0631\u0627\u0636 \u0627\u0644\u0646\u0627\u062f\u0631\u0629 \u0644\u0633\u0644\u0633\u0644\u0629 NORD \u0627\u0644\u062a\u0639\u0644\u064a\u0645\u064a\u0629. <\/p>","protected":false},"author":2,"featured_media":17213,"comment_status":"closed","ping_status":"closed","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"on","_et_pb_old_content":"","_et_gb_content_width":"","footnotes":"","_links_to":"","_links_to_target":""},"categories":[2,1],"tags":[],"class_list":["post-17197","post","type-post","status-publish","format-standard","has-post-thumbnail","hentry","category-news","category-uncategorized"],"yoast_head":"<!-- This site is optimized with the Yoast SEO plugin v27.8 - https:\/\/yoast.com\/product\/yoast-seo-wordpress\/ -->\n<title>nord | The Progeria Research Foundation<\/title>\n<meta name=\"description\" content=\"Hear PRF co-founder and Medical Director, Dr. Leslie Gordon, along with long-time colleague Dr. Francis Collins, share their journey in rare disease drug development for NORD educational series.\" \/>\n<meta name=\"robots\" content=\"index, follow, max-snippet:-1, max-image-preview:large, max-video-preview:-1\" \/>\n<link rel=\"canonical\" href=\"https:\/\/www.progeriaresearch.org\/ar\/2023\/07\/25\/nord\/\" \/>\n<meta property=\"og:locale\" content=\"ar_AR\" \/>\n<meta property=\"og:type\" content=\"article\" \/>\n<meta property=\"og:title\" content=\"nord | The Progeria Research Foundation\" \/>\n<meta property=\"og:description\" content=\"Hear PRF co-founder and Medical Director, Dr. Leslie Gordon, along with long-time colleague Dr. Francis Collins, share their journey in rare disease drug development for NORD educational series.\" \/>\n<meta property=\"og:url\" content=\"https:\/\/www.progeriaresearch.org\/ar\/2023\/07\/25\/nord\/\" \/>\n<meta property=\"og:site_name\" content=\"The Progeria Research Foundation\" \/>\n<meta property=\"article:publisher\" content=\"https:\/\/www.facebook.com\/ProgeriaResearch\/\" \/>\n<meta property=\"article:published_time\" content=\"2023-07-25T13:44:36+00:00\" \/>\n<meta property=\"article:modified_time\" content=\"2025-02-15T22:45:18+00:00\" \/>\n<meta property=\"og:image\" content=\"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2023\/07\/4LGFCNORD.png\" \/>\n\t<meta property=\"og:image:width\" content=\"1000\" \/>\n\t<meta property=\"og:image:height\" content=\"1000\" \/>\n\t<meta property=\"og:image:type\" content=\"image\/png\" \/>\n<meta name=\"author\" content=\"Karen Betournay\" \/>\n<meta name=\"twitter:card\" content=\"summary_large_image\" \/>\n<meta name=\"twitter:creator\" content=\"@Progeria\" \/>\n<meta name=\"twitter:site\" content=\"@Progeria\" \/>\n<meta name=\"twitter:label1\" content=\"Written by\" \/>\n\t<meta name=\"twitter:data1\" content=\"Karen Betournay\" \/>\n\t<meta name=\"twitter:label2\" content=\"Est. reading time\" \/>\n\t<meta name=\"twitter:data2\" content=\"\u062f\u0642\u064a\u0642\u062a\u0627\u0646\" \/>\n<script type=\"application\/ld+json\" class=\"yoast-schema-graph\">{\"@context\":\"https:\\\/\\\/schema.org\",\"@graph\":[{\"@type\":\"Article\",\"@id\":\"https:\\\/\\\/www.progeriaresearch.org\\\/2023\\\/07\\\/25\\\/nord\\\/#article\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.progeriaresearch.org\\\/2023\\\/07\\\/25\\\/nord\\\/\"},\"author\":{\"name\":\"Karen Betournay\",\"@id\":\"https:\\\/\\\/www.progeriaresearch.org\\\/ta\\\/#\\\/schema\\\/person\\\/2be6cec85c11aaef7a7602636c5b9946\"},\"headline\":\"PRF co-founder serves as thought leader in rare disease drug development\",\"datePublished\":\"2023-07-25T13:44:36+00:00\",\"dateModified\":\"2025-02-15T22:45:18+00:00\",\"mainEntityOfPage\":{\"@id\":\"https:\\\/\\\/www.progeriaresearch.org\\\/2023\\\/07\\\/25\\\/nord\\\/\"},\"wordCount\":435,\"publisher\":{\"@id\":\"https:\\\/\\\/www.progeriaresearch.org\\\/ta\\\/#organization\"},\"image\":{\"@id\":\"https:\\\/\\\/www.progeriaresearch.org\\\/2023\\\/07\\\/25\\\/nord\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.progeriaresearch.org\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/4LGFCNORD.png\",\"articleSection\":[\"News\",\"Uncategorized\"],\"inLanguage\":\"ar\"},{\"@type\":\"WebPage\",\"@id\":\"https:\\\/\\\/www.progeriaresearch.org\\\/2023\\\/07\\\/25\\\/nord\\\/\",\"url\":\"https:\\\/\\\/www.progeriaresearch.org\\\/2023\\\/07\\\/25\\\/nord\\\/\",\"name\":\"nord | The Progeria Research Foundation\",\"isPartOf\":{\"@id\":\"https:\\\/\\\/www.progeriaresearch.org\\\/ta\\\/#website\"},\"primaryImageOfPage\":{\"@id\":\"https:\\\/\\\/www.progeriaresearch.org\\\/2023\\\/07\\\/25\\\/nord\\\/#primaryimage\"},\"image\":{\"@id\":\"https:\\\/\\\/www.progeriaresearch.org\\\/2023\\\/07\\\/25\\\/nord\\\/#primaryimage\"},\"thumbnailUrl\":\"https:\\\/\\\/www.progeriaresearch.org\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/4LGFCNORD.png\",\"datePublished\":\"2023-07-25T13:44:36+00:00\",\"dateModified\":\"2025-02-15T22:45:18+00:00\",\"description\":\"Hear PRF co-founder and Medical Director, Dr. Leslie Gordon, along with long-time colleague Dr. Francis Collins, share their journey in rare disease drug development for NORD educational series.\",\"breadcrumb\":{\"@id\":\"https:\\\/\\\/www.progeriaresearch.org\\\/2023\\\/07\\\/25\\\/nord\\\/#breadcrumb\"},\"inLanguage\":\"ar\",\"potentialAction\":[{\"@type\":\"ReadAction\",\"target\":[\"https:\\\/\\\/www.progeriaresearch.org\\\/2023\\\/07\\\/25\\\/nord\\\/\"]}]},{\"@type\":\"ImageObject\",\"inLanguage\":\"ar\",\"@id\":\"https:\\\/\\\/www.progeriaresearch.org\\\/2023\\\/07\\\/25\\\/nord\\\/#primaryimage\",\"url\":\"https:\\\/\\\/www.progeriaresearch.org\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/4LGFCNORD.png\",\"contentUrl\":\"https:\\\/\\\/www.progeriaresearch.org\\\/wp-content\\\/uploads\\\/2023\\\/07\\\/4LGFCNORD.png\",\"width\":1000,\"height\":1000},{\"@type\":\"BreadcrumbList\",\"@id\":\"https:\\\/\\\/www.progeriaresearch.org\\\/2023\\\/07\\\/25\\\/nord\\\/#breadcrumb\",\"itemListElement\":[{\"@type\":\"ListItem\",\"position\":1,\"name\":\"Home\",\"item\":\"https:\\\/\\\/www.progeriaresearch.org\\\/\"},{\"@type\":\"ListItem\",\"position\":2,\"name\":\"PRF co-founder serves as thought leader in rare disease drug development\"}]},{\"@type\":\"WebSite\",\"@id\":\"https:\\\/\\\/www.progeriaresearch.org\\\/ta\\\/#website\",\"url\":\"https:\\\/\\\/www.progeriaresearch.org\\\/ta\\\/\",\"name\":\"The Progeria Research Foundation\",\"description\":\"For the Children \u2665 For the Cure\",\"publisher\":{\"@id\":\"https:\\\/\\\/www.progeriaresearch.org\\\/ta\\\/#organization\"},\"potentialAction\":[{\"@type\":\"SearchAction\",\"target\":{\"@type\":\"EntryPoint\",\"urlTemplate\":\"https:\\\/\\\/www.progeriaresearch.org\\\/ta\\\/?s={search_term_string}\"},\"query-input\":{\"@type\":\"PropertyValueSpecification\",\"valueRequired\":true,\"valueName\":\"search_term_string\"}}],\"inLanguage\":\"ar\"},{\"@type\":\"Organization\",\"@id\":\"https:\\\/\\\/www.progeriaresearch.org\\\/ta\\\/#organization\",\"name\":\"The Progeria Research Foundation\",\"url\":\"https:\\\/\\\/www.progeriaresearch.org\\\/ta\\\/\",\"logo\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ar\",\"@id\":\"https:\\\/\\\/www.progeriaresearch.org\\\/ta\\\/#\\\/schema\\\/logo\\\/image\\\/\",\"url\":\"https:\\\/\\\/www.progeriaresearch.org\\\/wp-content\\\/uploads\\\/2019\\\/05\\\/PRF_Logo_2019_optimized.png\",\"contentUrl\":\"https:\\\/\\\/www.progeriaresearch.org\\\/wp-content\\\/uploads\\\/2019\\\/05\\\/PRF_Logo_2019_optimized.png\",\"width\":300,\"height\":86,\"caption\":\"The Progeria Research Foundation\"},\"image\":{\"@id\":\"https:\\\/\\\/www.progeriaresearch.org\\\/ta\\\/#\\\/schema\\\/logo\\\/image\\\/\"},\"sameAs\":[\"https:\\\/\\\/www.facebook.com\\\/ProgeriaResearch\\\/\",\"https:\\\/\\\/x.com\\\/Progeria\",\"https:\\\/\\\/www.instagram.com\\\/progeriaresearch\\\/\"]},{\"@type\":\"Person\",\"@id\":\"https:\\\/\\\/www.progeriaresearch.org\\\/ta\\\/#\\\/schema\\\/person\\\/2be6cec85c11aaef7a7602636c5b9946\",\"name\":\"Karen Betournay\",\"image\":{\"@type\":\"ImageObject\",\"inLanguage\":\"ar\",\"@id\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/78c0520933a7d708c5e1a5788ec6799d5e2ad6a2a6d4ff2ca1e512861d12f533?s=96&d=mm&r=g\",\"url\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/78c0520933a7d708c5e1a5788ec6799d5e2ad6a2a6d4ff2ca1e512861d12f533?s=96&d=mm&r=g\",\"contentUrl\":\"https:\\\/\\\/secure.gravatar.com\\\/avatar\\\/78c0520933a7d708c5e1a5788ec6799d5e2ad6a2a6d4ff2ca1e512861d12f533?s=96&d=mm&r=g\",\"caption\":\"Karen Betournay\"},\"url\":\"https:\\\/\\\/www.progeriaresearch.org\\\/ar\\\/author\\\/karenb\\\/\"}]}<\/script>\n<!-- \/ Yoast SEO plugin. -->","yoast_head_json":{"title":"nord | The Progeria Research Foundation","description":"\u0627\u0633\u062a\u0645\u0639 \u0625\u0644\u0649 \u0627\u0644\u0645\u0624\u0633\u0633 \u0627\u0644\u0645\u0634\u0627\u0631\u0643 \u0648\u0627\u0644\u0645\u062f\u064a\u0631 \u0627\u0644\u0637\u0628\u064a \u0644\u0640 PRF\u060c \u0627\u0644\u062f\u0643\u062a\u0648\u0631 \u0644\u064a\u0632\u0644\u064a \u062c\u0648\u0631\u062f\u0648\u0646\u060c \u0625\u0644\u0649 \u062c\u0627\u0646\u0628 \u0632\u0645\u064a\u0644\u0647 \u0627\u0644\u0642\u062f\u064a\u0645 \u0627\u0644\u062f\u0643\u062a\u0648\u0631 \u0641\u0631\u0627\u0646\u0633\u064a\u0633 \u0643\u0648\u0644\u064a\u0646\u0632\u060c \u064a\u0634\u0627\u0631\u0643\u0627\u0646 \u0631\u062d\u0644\u062a\u0647\u0645\u0627 \u0641\u064a \u062a\u0637\u0648\u064a\u0631 \u0623\u062f\u0648\u064a\u0629 \u0627\u0644\u0623\u0645\u0631\u0627\u0636 \u0627\u0644\u0646\u0627\u062f\u0631\u0629 \u0644\u0633\u0644\u0633\u0644\u0629 NORD \u0627\u0644\u062a\u0639\u0644\u064a\u0645\u064a\u0629.","robots":{"index":"index","follow":"follow","max-snippet":"max-snippet:-1","max-image-preview":"max-image-preview:large","max-video-preview":"max-video-preview:-1"},"canonical":"https:\/\/www.progeriaresearch.org\/ar\/2023\/07\/25\/nord\/","og_locale":"ar_AR","og_type":"article","og_title":"nord | The Progeria Research Foundation","og_description":"Hear PRF co-founder and Medical Director, Dr. Leslie Gordon, along with long-time colleague Dr. Francis Collins, share their journey in rare disease drug development for NORD educational series.","og_url":"https:\/\/www.progeriaresearch.org\/ar\/2023\/07\/25\/nord\/","og_site_name":"The Progeria Research Foundation","article_publisher":"https:\/\/www.facebook.com\/ProgeriaResearch\/","article_published_time":"2023-07-25T13:44:36+00:00","article_modified_time":"2025-02-15T22:45:18+00:00","og_image":[{"width":1000,"height":1000,"url":"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2023\/07\/4LGFCNORD.png","type":"image\/png"}],"author":"Karen Betournay","twitter_card":"summary_large_image","twitter_creator":"@Progeria","twitter_site":"@Progeria","twitter_misc":{"Written by":"Karen Betournay","Est. reading time":"\u062f\u0642\u064a\u0642\u062a\u0627\u0646"},"schema":{"@context":"https:\/\/schema.org","@graph":[{"@type":"Article","@id":"https:\/\/www.progeriaresearch.org\/2023\/07\/25\/nord\/#article","isPartOf":{"@id":"https:\/\/www.progeriaresearch.org\/2023\/07\/25\/nord\/"},"author":{"name":"Karen Betournay","@id":"https:\/\/www.progeriaresearch.org\/ta\/#\/schema\/person\/2be6cec85c11aaef7a7602636c5b9946"},"headline":"PRF co-founder serves as thought leader in rare disease drug development","datePublished":"2023-07-25T13:44:36+00:00","dateModified":"2025-02-15T22:45:18+00:00","mainEntityOfPage":{"@id":"https:\/\/www.progeriaresearch.org\/2023\/07\/25\/nord\/"},"wordCount":435,"publisher":{"@id":"https:\/\/www.progeriaresearch.org\/ta\/#organization"},"image":{"@id":"https:\/\/www.progeriaresearch.org\/2023\/07\/25\/nord\/#primaryimage"},"thumbnailUrl":"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2023\/07\/4LGFCNORD.png","articleSection":["News","Uncategorized"],"inLanguage":"ar"},{"@type":"WebPage","@id":"https:\/\/www.progeriaresearch.org\/2023\/07\/25\/nord\/","url":"https:\/\/www.progeriaresearch.org\/2023\/07\/25\/nord\/","name":"nord | The Progeria Research Foundation","isPartOf":{"@id":"https:\/\/www.progeriaresearch.org\/ta\/#website"},"primaryImageOfPage":{"@id":"https:\/\/www.progeriaresearch.org\/2023\/07\/25\/nord\/#primaryimage"},"image":{"@id":"https:\/\/www.progeriaresearch.org\/2023\/07\/25\/nord\/#primaryimage"},"thumbnailUrl":"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2023\/07\/4LGFCNORD.png","datePublished":"2023-07-25T13:44:36+00:00","dateModified":"2025-02-15T22:45:18+00:00","description":"\u0627\u0633\u062a\u0645\u0639 \u0625\u0644\u0649 \u0627\u0644\u0645\u0624\u0633\u0633 \u0627\u0644\u0645\u0634\u0627\u0631\u0643 \u0648\u0627\u0644\u0645\u062f\u064a\u0631 \u0627\u0644\u0637\u0628\u064a \u0644\u0640 PRF\u060c \u0627\u0644\u062f\u0643\u062a\u0648\u0631 \u0644\u064a\u0632\u0644\u064a \u062c\u0648\u0631\u062f\u0648\u0646\u060c \u0625\u0644\u0649 \u062c\u0627\u0646\u0628 \u0632\u0645\u064a\u0644\u0647 \u0627\u0644\u0642\u062f\u064a\u0645 \u0627\u0644\u062f\u0643\u062a\u0648\u0631 \u0641\u0631\u0627\u0646\u0633\u064a\u0633 \u0643\u0648\u0644\u064a\u0646\u0632\u060c \u064a\u0634\u0627\u0631\u0643\u0627\u0646 \u0631\u062d\u0644\u062a\u0647\u0645\u0627 \u0641\u064a \u062a\u0637\u0648\u064a\u0631 \u0623\u062f\u0648\u064a\u0629 \u0627\u0644\u0623\u0645\u0631\u0627\u0636 \u0627\u0644\u0646\u0627\u062f\u0631\u0629 \u0644\u0633\u0644\u0633\u0644\u0629 NORD \u0627\u0644\u062a\u0639\u0644\u064a\u0645\u064a\u0629.","breadcrumb":{"@id":"https:\/\/www.progeriaresearch.org\/2023\/07\/25\/nord\/#breadcrumb"},"inLanguage":"ar","potentialAction":[{"@type":"ReadAction","target":["https:\/\/www.progeriaresearch.org\/2023\/07\/25\/nord\/"]}]},{"@type":"ImageObject","inLanguage":"ar","@id":"https:\/\/www.progeriaresearch.org\/2023\/07\/25\/nord\/#primaryimage","url":"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2023\/07\/4LGFCNORD.png","contentUrl":"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2023\/07\/4LGFCNORD.png","width":1000,"height":1000},{"@type":"BreadcrumbList","@id":"https:\/\/www.progeriaresearch.org\/2023\/07\/25\/nord\/#breadcrumb","itemListElement":[{"@type":"ListItem","position":1,"name":"Home","item":"https:\/\/www.progeriaresearch.org\/"},{"@type":"ListItem","position":2,"name":"PRF co-founder serves as thought leader in rare disease drug development"}]},{"@type":"WebSite","@id":"https:\/\/www.progeriaresearch.org\/ta\/#website","url":"https:\/\/www.progeriaresearch.org\/ta\/","name":"\u0645\u0624\u0633\u0633\u0629 \u0623\u0628\u062d\u0627\u062b \u0645\u0631\u0636 \u0627\u0644\u0634\u064a\u062e\u0648\u062e\u0629 \u0627\u0644\u0645\u0628\u0643\u0631\u0629","description":"\u0645\u0646 \u0623\u062c\u0644 \u0627\u0644\u0623\u0637\u0641\u0627\u0644 \u2665 \u0645\u0646 \u0623\u062c\u0644 \u0627\u0644\u0639\u0644\u0627\u062c","publisher":{"@id":"https:\/\/www.progeriaresearch.org\/ta\/#organization"},"potentialAction":[{"@type":"SearchAction","target":{"@type":"EntryPoint","urlTemplate":"https:\/\/www.progeriaresearch.org\/ta\/?s={search_term_string}"},"query-input":{"@type":"PropertyValueSpecification","valueRequired":true,"valueName":"search_term_string"}}],"inLanguage":"ar"},{"@type":"Organization","@id":"https:\/\/www.progeriaresearch.org\/ta\/#organization","name":"\u0645\u0624\u0633\u0633\u0629 \u0623\u0628\u062d\u0627\u062b \u0645\u0631\u0636 \u0627\u0644\u0634\u064a\u062e\u0648\u062e\u0629 \u0627\u0644\u0645\u0628\u0643\u0631\u0629","url":"https:\/\/www.progeriaresearch.org\/ta\/","logo":{"@type":"ImageObject","inLanguage":"ar","@id":"https:\/\/www.progeriaresearch.org\/ta\/#\/schema\/logo\/image\/","url":"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2019\/05\/PRF_Logo_2019_optimized.png","contentUrl":"https:\/\/www.progeriaresearch.org\/wp-content\/uploads\/2019\/05\/PRF_Logo_2019_optimized.png","width":300,"height":86,"caption":"The Progeria Research Foundation"},"image":{"@id":"https:\/\/www.progeriaresearch.org\/ta\/#\/schema\/logo\/image\/"},"sameAs":["https:\/\/www.facebook.com\/ProgeriaResearch\/","https:\/\/x.com\/Progeria","https:\/\/www.instagram.com\/progeriaresearch\/"]},{"@type":"Person","@id":"https:\/\/www.progeriaresearch.org\/ta\/#\/schema\/person\/2be6cec85c11aaef7a7602636c5b9946","name":"\u0643\u0627\u0631\u064a\u0646 \u0628\u064a\u062a\u0648\u0631\u0646\u0627\u064a","image":{"@type":"ImageObject","inLanguage":"ar","@id":"https:\/\/secure.gravatar.com\/avatar\/78c0520933a7d708c5e1a5788ec6799d5e2ad6a2a6d4ff2ca1e512861d12f533?s=96&d=mm&r=g","url":"https:\/\/secure.gravatar.com\/avatar\/78c0520933a7d708c5e1a5788ec6799d5e2ad6a2a6d4ff2ca1e512861d12f533?s=96&d=mm&r=g","contentUrl":"https:\/\/secure.gravatar.com\/avatar\/78c0520933a7d708c5e1a5788ec6799d5e2ad6a2a6d4ff2ca1e512861d12f533?s=96&d=mm&r=g","caption":"Karen Betournay"},"url":"https:\/\/www.progeriaresearch.org\/ar\/author\/karenb\/"}]}},"_links":{"self":[{"href":"https:\/\/www.progeriaresearch.org\/ar\/wp-json\/wp\/v2\/posts\/17197","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/www.progeriaresearch.org\/ar\/wp-json\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/www.progeriaresearch.org\/ar\/wp-json\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/www.progeriaresearch.org\/ar\/wp-json\/wp\/v2\/users\/2"}],"replies":[{"embeddable":true,"href":"https:\/\/www.progeriaresearch.org\/ar\/wp-json\/wp\/v2\/comments?post=17197"}],"version-history":[{"count":0,"href":"https:\/\/www.progeriaresearch.org\/ar\/wp-json\/wp\/v2\/posts\/17197\/revisions"}],"wp:featuredmedia":[{"embeddable":true,"href":"https:\/\/www.progeriaresearch.org\/ar\/wp-json\/wp\/v2\/media\/17213"}],"wp:attachment":[{"href":"https:\/\/www.progeriaresearch.org\/ar\/wp-json\/wp\/v2\/media?parent=17197"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/www.progeriaresearch.org\/ar\/wp-json\/wp\/v2\/categories?post=17197"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/www.progeriaresearch.org\/ar\/wp-json\/wp\/v2\/tags?post=17197"}],"curies":[{"name":"\u0648\u0648\u0631\u062f\u0628\u0631\u064a\u0633","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}